Clinical Scorecard: Periodontal Disease and ASCVD: Updated
At a Glance
Category
Detail
Condition
Key Mechanisms
Direct mechanisms include bacteremia, vascular infection, and autoimmune responses; indirect mechanisms involve systemic inflammation and elevated inflammatory markers.
Target Population
Care Setting
Key Highlights
42% of U.S. adults aged 30+ have periodontitis; 7.8% have severe disease.
Periodontal disease shares risk factors with ASCVD, including diabetes and hypertension.
Associations exist between periodontal disease and various cardiovascular outcomes.
Interventional studies show inconclusive results on periodontal treatment reducing ASCVD events.
Disparities in periodontal disease prevalence overlap with those in ASCVD.
Interventional studies have not demonstrated definitive reductions in ASCVD events following periodontal therapy.
Guideline-Based Recommendations
Diagnosis
Monitor periodontal disease prevalence and associated cardiovascular risks.
Management
Identify and treat periodontal disease to potentially decrease inflammation and promote cardiovascular health.
Encourage further research into the causal relationship between periodontal disease and ASCVD.
Monitoring & Follow-up
Evaluate inflammatory markers, blood pressure, and endothelial function in patients with periodontal disease.
Risks
Consider shared risk factors such as socioeconomic status and access to dental care.
Patient & Prescribing Data
Improvement in intermediate outcomes like inflammatory markers and endothelial function has been observed, but definitive reductions in ASCVD events are not established.
Clinical Best Practices
Encourage interdisciplinary collaboration between dental and cardiovascular health professionals.
Promote further research into the causal relationship between periodontal disease and ASCVD.
